Thyrocare Technologies shares zoomed 12.66 per cent in trade, hitting a 52-week high at ₹1,356.95 per share on the BSE.

Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...

Thyrocare’s consolidated net profit rose 59.9% to INR 38.3 Cr in Q1 FY26 from INR 23.9 Cr in the year-ago quarter ...

Thyrocare founder Dr. A Velumani sparks debate with his viral video criticizing the over-scheduling of city children. He ...

Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new ...

Dr A Velumani urged parents to rethink the pressures of over-scheduling in urban childhoods, advocating instead for a slower ...

Real-time updates on THYROCARE TECHNOLOGIES share price. Check out the detailed analysis of the company in this live blog.

Thyrocare Technologies Limited reported a 62% year-on-year increase in profit after tax (PAT) to ₹38.06 crore for the quarter ended June 30, 2025. The company's revenue from operations grew by 23% to ...

Thyrocare Technologies surged 11.30% to Rs 1,340.55 after the healthcare service provider reported a 61.07% increase in consolidated net profit to Rs 38.93 crore on a 23.02% rise in revenue from ...

Net Sales at Rs 178.89 crore in June 2025 up 24.55% from Rs. 143.63 crore in June 2024. Quarterly Net Profit at Rs. 36.05 crore in June 2025 up 43.34% from Rs. 25.15 crore in June 2024. EBITDA stands ...

Thyrocare Technologies delivered excellent results in Q1. Both the company’s revenue and profit have increased. CEO Rahul Guha expressed optimism for faster growth in FY26. In an exclusive ...

Thyrocare Technologies' shares soared 13% after reporting a 60% YoY surge in Q1 net profit, bolstered by strong operational revenue growth.